← Leaderboards
Joshua James Reineke
Stellenbosch University
$544,089
Attributed
$1,632,268
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $345.6K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,632,268 · 1
By mechanism
R01$1,632,268 · 1
Top collaborators
- Admire Dube5 shared
- Samantha Leigh Sampson5 shared
Most similar at Stellenbosch University
Same institution · by research overlap
- Samantha Leigh Sampson$1,007,841
- Erick Strauss$675,183
- Marisa Klopper$318,264
- John T Belisle$22,161,703
- Elizabeth Maria Streicher$710,388
Others in their field
Other Emerging Leaders on “Co-Infection”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Thomas Denny · Duke University$23,095,705
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,639,518
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$15,395,607
- Kevin Urdahl · Seattle Children'S Hospital$14,358,263
- Sara Albert · Leidos Biomedical Research, Inc.$9,235,930
Research focus
Co-InfectionAdherenceAnimal ModelAdvanced DevelopmentAntibioticsAlveolar MacrophagesAntimicrobial EffectAppearanceAntibacterial ResponseArtificial NanoparticlesAwardBacteriaBacterial InfectionsAntimicrobialBeta-GlucansBiocompatible MaterialsBiomimeticsBone MarrowArchitectureCase StudyCause Of DeathCellsCessation Of LifeCommunicable Diseases
Grant awards (5)
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$303,416
R01 · FY2024 · AI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$318,225
R01 · FY2023 · AI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$328,171
R01 · FY2022 · AI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$336,887
R01 · FY2021 · AI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$345,569
R01 · FY2020 · AI